Can SaaS Companies Access European R&D Grants?

The misconception about software and R&D grants

The most common mistake SaaS founders make when evaluating European funding is assuming that "R&D" means laboratory science. It doesn't. R&D, for grant purposes, is defined as work aimed at resolving genuine technical uncertainty — i.e., developing something that a competent software engineer could not simply build by applying known techniques.

Eurostars — one of Europe's most popular R&D grant programmes — consistently funds pure software and SaaS projects. The key is demonstrating that your product development involves genuine technical innovation, not just engineering execution.

What R&D looks like in a SaaS company

Here are examples of software development activities that constitute eligible R&D:

• Novel algorithm development: Creating new algorithms for search, ranking, recommendation or optimisation that go beyond known approaches.
• Proprietary data processing pipelines: Developing new methods for data ingestion, transformation, normalisation or enrichment at scale.
• AI/ML model development: Building custom models (not just API wrapping) for classification, prediction, clustering or generation tasks.
• Distributed systems research: Solving novel consistency, latency or scalability problems in multi-tenant architectures.
• Security and cryptography: Developing new approaches to data protection, zero-knowledge proofs, or privacy-preserving computation.
• Domain-specific language and compiler work: Building DSLs, query engines, or compilers for specialised SaaS use cases.

The best programmes for SaaS companies

Eurostars (up to €500K)

Eurostars is the most accessible route for SaaS companies. The programme explicitly welcomes software-only R&D projects and does not require an academic partner. A SaaS company with an active engineering team working on novel technical problems and a qualifying international partner can apply. The grant typically covers 35–60% of project costs, depending on the partner countries.

National R&D grants (up to €500K)

Germany's ZIM programme, the Netherlands' WBSO tax credit, France's BPI grants, and Cyprus's RPF all fund software R&D. National programmes tend to be faster (3–6 months to award) and accept solo applicants — making them ideal for earlier-stage SaaS companies not yet ready for international collaboration.

EIC Accelerator (up to €2.5M + equity)

For SaaS companies with genuinely breakthrough products — think category-defining, high-growth, winner-take-most dynamics — the EIC Accelerator offers the largest non-dilutive grant package in Europe. The bar is high (5–10% success rate) but the rewards are transformational.

The "product development vs. R&D" distinction

The critical distinction grant reviewers apply is between routine development (applying known techniques to build something that is new to the company but not technically uncertain) and genuine R&D (addressing problems where the technical solution is not predictable in advance). Both can happen within the same sprint. The skill of writing a fundable application is articulating the R&D dimension precisely — without overstating novelty or understating the genuine technical challenge.

European Funding Agency has written successful SaaS R&D applications for companies where the core product appeared entirely standard from a marketing perspective but contained genuinely novel algorithmic approaches that reviewers could identify and reward.

Combining grants with VC funding

European grants are fully compatible with VC investment. There is no requirement to choose between non-dilutive funding and equity. In fact, grants strengthen your VC position — they validate the R&D quality of your technology, reduce cash burn, and extend runway. Many investors actively view European grant history as a positive signal in due diligence.

The practical stack looks like this: national R&D grant or Eurostars running in parallel with Seed or Series A, covering R&D payroll costs. This effectively reduces the equity-funded burn rate while maintaining the R&D velocity that drives valuation.